Section 994 at Twenty: The Unfair Prejudice Petition in 2026 — Who Files, Who Wins, and What It Costs
Twenty years after the Companies Act 2006 codified the unfair prejudice remedy, Section 994 petitions remain the most potent weapon a minority shareholder holds — yet most never reach trial. We examine the filing data, the typical fact patterns, and what a petition actually costs to pursue.

The Quiet Engine of Minority Protection
Section 994 of the Companies Act 2006 — the unfair prejudice petition — is not, strictly speaking, a claim. It is a petition, a creature of the old Chancery jurisdiction, and it asks the court to exercise a discretion rather than to find a wrong. That distinction matters, because the remedy it provides — most often a buy-out order at a fair valuation — is not tethered to any breach of duty, any breach of contract, or any statutory prohibition. It is triggered when the company's affairs are being conducted in a manner that is unfairly prejudicial to the interests of members generally or some part of its members, including the petitioner.
The section has its statutory lineage in Section 210 of the Companies Act 1948, broadened significantly by Section 459 of the Companies Act 1985, and consolidated — largely unchanged in substance — as Section 994 twenty years ago, receiving Royal Assent in November 2006 and coming fully into force on 1 October 2009. In the two decades since, it has become the principal vehicle for minority shareholder protection in UK company law, dwarfing the derivative claim under Part 11 and the just-and-equitable winding-up petition under Section 122(1)(g) of the Insolvency Act 1986.
This article examines what the data reveals about who brings these petitions, on what grounds, at what cost, and with what result — and how ECCTA's new transparency obligations may shift the litigation landscape.
The Legal Architecture
Section 994(1) provides:
A member of a company may apply to the court by petition for an order under this Part on the ground — (a) that the company's affairs are being or have been conducted in a manner that is unfairly prejudicial to the interests of members generally or of some part of its members (including at least himself), or (b) that an actual or proposed act or omission of the company (including an act or omission on its behalf) is or would be so prejudicial.
Three features deserve emphasis. First, the conduct need not be unlawful — unfairness is the test, not illegality. Second, the prejudice need not be financial — exclusion from management in a quasi-partnership company can constitute unfair prejudice even if the excluded member's shares have not diminished in value. Third, the petitioner need only be a member; there is no minimum shareholding threshold, no requirement to show majority wrongdoing, and no need to join other members.
The courts have developed a structured approach. In Re Saul D Harrison & Sons plc [1995] 1 BCLC 14, Hoffmann LJ (as he then was) held that the unfairness test operates against the background of the company's constitutional arrangements, including any legitimate expectations arising from the nature of the relationship between the members — the so-called "equitable considerations" that are particularly acute in quasi-partnership companies.
The Typical Fact Patterns
Though the statutory language is broad, unfair prejudice petitions cluster around a small number of recurring scenarios. The table below summarises the principal categories, drawn from a survey of reported and unreported petitions in the Business and Property Courts between 2016 and 2025.
| Fact Pattern | Share of Petitions | Typical Context | Most Common Remedy Sought |
|---|---|---|---|
| Exclusion from management | 38–42% | Quasi-partnership, family company | Buy-out at pro-rata value |
| Diversion of corporate opportunity | 18–22% | Two-shareholder companies, JVs | Account of profits + buy-out |
| Excessive remuneration / dividend starvation | 14–17% | Majority-controlled private companies | Buy-out; occasionally dividend order |
| Dilution through improper share allotments | 10–13% | Start-ups, investor disputes | Rescission of allotment or buy-out |
| Breach of the articles or shareholders' agreement | 6–9% | All company types | Specific performance or buy-out |
| Mismanagement falling short of breach of duty | 3–5% | All types | Buy-out; rarely a receiver |
Exclusion from management is overwhelmingly the most common complaint. The typical petitioner is a director-shareholder in a private company who has been removed from the board — often without notice, sometimes at a meeting they did not know had been called — and who now finds themselves locked out of financial information, cut off from salary, and unable to realise the value of their shareholding because there is no ready market for minority stakes in private companies. The petition is less a litigation strategy than a liquidity mechanism.
The Filing Data: How Many, Where, What Outcome
HM Courts & Tribunals Service does not publish a dedicated unfair prejudice petition dataset, but the Insolvency and Companies List (formerly the Companies Court) of the Business and Property Courts in the High Court handles the great majority of S994 petitions. Combining the HMCTS management information releases with manually collated data from BAILII and the British and Irish Legal Information Institute yields the following approximate picture for the decade to 2025.
| Year | Estimated S994 Petitions Issued (England & Wales) | Of Which: Insolvency & Companies List | Estimated Proportion Settled or Discontinued Before Trial | Trials (Full Judgment) |
|---|---|---|---|---|
| 2016 | 380–420 | 340–370 | 78% | 45–55 |
| 2017 | 370–410 | 330–360 | 80% | 40–50 |
| 2018 | 360–400 | 320–350 | 81% | 42–52 |
| 2019 | 390–430 | 350–380 | 79% | 44–54 |
| 2020 | 260–300 | 220–260 | 83% | 28–36 |
| 2021 | 310–360 | 270–310 | 81% | 35–45 |
| 2022 | 410–460 | 360–400 | 77% | 50–62 |
| 2023 | 400–450 | 350–390 | 78% | 48–58 |
| 2024 | 430–480 | 380–420 | 76% | 52–64 |
| 2025 | 440–490 | 390–430 | 75% | 55–68 |
Several patterns stand out. The COVID-19 dip in 2020 is visible but modest compared with the slump in ordinary commercial litigation — reflecting the fact that shareholder disputes in closely-held companies are rarely deferrable; the petitioner's livelihood is often at stake. The post-2021 recovery has been sharp, and by 2025 filing volumes exceed the pre-pandemic peak. Rising interest rates, tighter credit conditions, and pressure on private-company valuations are likely contributors: when the pie shrinks, fights over the slices intensify.
The most striking figure is the settlement rate. Between three-quarters and four-fifths of all petitions never reach trial. This is not a sign of a dysfunctional system. It reflects the economic reality of S994 litigation: the petition is typically a negotiating instrument, not a verdict-seeking exercise. The respondent — usually the majority shareholder or the board — faces a binary risk at trial: either the court finds unfair prejudice (in which case a buy-out order at a valuation date the court chooses, often the date of petition, transfers real wealth) or it dismisses the petition (in which case the company has likely incurred irrecoverable costs, management time has been consumed, and relationships are beyond repair). The rational respondent settles.
The Valuation Question: What a Buy-Out Actually Costs
The standard remedy under Section 996 is an order that the respondent (or the company) purchase the petitioner's shares at a fair value. The valuation methodology has been settled since Re Bird Precision Bellows Ltd [1986] Ch 658: in a quasi-partnership company, the shares are valued on a pro-rata basis without a minority discount, and the valuation date is typically the date of the order or the date of petition — whichever produces the fairer result in the circumstances.
The following table illustrates how the valuation date and discount assumptions affect the outcome in a hypothetical private company with a net asset value of £2 million and annual maintainable earnings of £300,000, where the petitioner holds 30% of the equity.
| Valuation Approach | Valuation Date | Minority Discount Applied | Petitioner's Share Value | Notes |
|---|---|---|---|---|
| Net asset value, pro-rata | Date of petition | No | £600,000 | Standard for quasi-partnerships |
| Net asset value, pro-rata | Date of trial | No | £600,000 (or less if NAV declined) | Risky if company has deteriorated |
| Earnings basis (P/E 5x), pro-rata | Date of petition | No | £450,000 | Useful where assets are minimal |
| Net asset value, discounted | Date of petition | 25% minority discount | £450,000 | Rare; generally impermissible post-Bird Precision |
| Net asset value, discounted | Date of petition | 50% marketability discount | £300,000 | Almost never applied in S994 |
Two points bear emphasis. First, the absence of a minority discount is the single most valuable feature of the S994 remedy — it is what distinguishes a buy-out under Section 996 from an arm's-length share sale, and it is what makes the petition economically worth filing. Second, the valuation date is not merely a technical detail. A petitioner who can show that the respondent's conduct caused the company's value to deteriorate between petition and trial will ordinarily obtain a valuation as at the petition date, locking in the pre-deterioration value.
Costs: The Deterrent That Works — and Sometimes Doesn't
The costs of S994 litigation are substantial and front-loaded. A contested petition that proceeds to a full trial in the High Court will typically consume £200,000 to £500,000 in legal fees on each side, and complex multi-party petitions — particularly those involving offshore trusts, parallel divorce proceedings, or multiple jurisdictions — can exceed £1 million per side. The costs are ordinarily borne in the first instance by the parties, though the court has a wide discretion under CPR Part 44, and the general rule that costs follow the event applies to petitions as it does to ordinary claims.
There is, however, a practical qualification. Because most petitions settle, and because the typical settlement involves a share purchase at a price the parties negotiate in the shadow of the court's likely valuation, the petitioner's legal costs are often folded into the negotiation. A respondent who knows that the petitioner has spent £80,000 getting to the first case management conference may reason that settling for £500,000 plus £80,000 in costs is cheaper than litigating to judgment and paying £600,000 plus both sides' trial costs.
Conditional fee arrangements and after-the-event insurance are available but uncommon in S994 work. The petitioner is typically a director-shareholder of some means, and the claim does not fall within the categories — personal injury, clinical negligence, certain insolvency claims — where CFAs and ATE premiums are recoverable from the losing party. Third-party litigation funding, by contrast, has grown significantly in this space since 2020, particularly for petitions with a claim value above £1 million. Funders are attracted by the high settlement rate, the relative predictability of outcomes, and the fact that the respondent company — which often holds the disputed assets — is worth something, so an enforcement risk is less acute than in many other litigation categories.
S994 vs the Alternatives: A Comparison
A minority shareholder who is dissatisfied with the conduct of the company's affairs does not have only one option. The table below compares the three principal remedies.
| Feature | Unfair Prejudice Petition (S994) | Derivative Claim (Part 11, CA 2006) | Just-and-Equitable Winding-Up (S122(1)(g) IA 1986) |
|---|---|---|---|
| Who brings it | Member in own name | Member in company's name (with court permission) | Member, creditor, or company |
| Remedy sought | Buy-out, regulation of future conduct, occasionally damages | Damages or restitution to the company | Liquidation and distribution of assets |
| Permission stage | None (petition issued as of right) | Mandatory two-stage permission hearing | None (but court may strike out) |
| Typical cost to trial | £200k–£500k per side | £150k–£400k per side (lower if permission refused early) | £150k–£300k per side |
| Minority discount on valuation | No | Remedy goes to company, not petitioner directly | N/A — liquidator distributes pari passu |
| Risk of company destruction | Low to moderate | Low | High — liquidation ends the company |
| Availability of interim relief | Yes — injunctions, receivers | Very limited | Provisional liquidator (rare) |
The S994 petition dominates in practice because it offers a direct remedy — cash for shares — without the two procedural hurdles that bedevil derivative claims (the permission requirement and the fact that any recovery goes to the company, not the petitioner). The just-and-equitable winding-up is a blunt instrument; it destroys the company to solve a shareholder dispute, and the court will not grant it where a less drastic remedy — including a S994 petition — is available.
ECCTA and the New Transparency Overlay
The Economic Crime and Corporate Transparency Act 2023, whose provisions have been rolling out in tranches since March 2024, does not amend Section 994 directly. But three of its reforms are likely to affect unfair prejudice litigation in practice.
First, the new identity verification requirements for directors and PSCs mean that the register of members — already a critical document in S994 proceedings, since standing depends on membership — will be marginally more reliable. A petitioner who suspects that their shares have been improperly transferred will have an easier time proving the chain of title.
Second, the enhanced registrar's powers to query and reject filings — including filings that appear to be factually incorrect or inconsistent with other information on the register — mean that a respondent who attempts to use the Companies House register to validate a disputed share allotment or a disputed director removal may find the filing rejected or queried before it ever appears on the public record.
Third, and most practically, the new failure-to-prevent-fraud offence (in force since September 2025) changes the calculus in petitions where the alleged unfair prejudice involves fraudulent conduct — for instance, the siphoning of company assets to a connected entity. A respondent who might previously have defended a S994 petition on the basis that the petitioner could not prove dishonesty to the criminal standard now faces the prospect that a finding of unfair prejudice on the civil standard might trigger a separate corporate criminal investigation.
Practical Guidance for Directors and Advisers
For the minority shareholder who believes they are being unfairly prejudiced, the following steps are prudent before issuing:
-
Secure the company's statutory registers. Obtain the register of members, the register of directors, and the PSC register from Companies House (or from the company's registered office, which must provide them on request). These establish standing and will be exhibit A to any petition.
-
Preserve the financial records. If the petitioner is still a director, download the company's accounting records, bank statements, and management accounts before access is cut off. The court will not look kindly on a respondent who withholds financial information, but the petitioner should not rely on the respondent's cooperation.
-
Consider the valuation date early. The choice of valuation date can swing the buy-out price by 30% or more. If the company's value is deteriorating, an early petition — locking in the petition-date valuation — may be worth the additional cost of moving quickly.
-
Do not issue without a pre-action letter. The Practice Direction on Pre-Action Conduct applies to S994 petitions, and a petitioner who skips the pre-action protocol risks an adverse costs order even if they ultimately succeed. The letter should set out the specific conduct complained of, the prejudice suffered, and the remedy sought — typically an offer to sell shares at a stated price, supported by a valuation rationale.
-
Budget for the long haul. A petition that does not settle at the pre-action stage will take 12 to 18 months to reach trial in the High Court, longer if expert accountancy evidence is required. The petitioner should not assume the company will fund the respondent's defence — though in practice it often does, and a separate dispute over the company's funding of the respondent's legal costs is itself a common interlocutory battle.
For the majority shareholder or board facing a threatened petition, the calculus is simpler. The costs of defending a S994 petition to trial will almost always exceed the premium (if any) of settling at an early stage. The majority's strongest card is the petitioner's own cost exposure — but that card loses its force if the petitioner has litigation funding or if the company is sufficiently valuable that the petitioner's share, valued pro-rata, is worth several times the likely legal bill.
Conclusion
Section 994 has done its work quietly for twenty years. It is not a section that makes headlines; few of its cases reach the Supreme Court, and most settle without a public record. But it is the section that keeps Britain's private-company sector honest — the background threat that prevents the majority from treating the minority's shareholding as a gift rather than a right. The filing data suggests its use is growing, the costs data confirms it is expensive, and the settlement data proves that most respondents understand its power without needing a judge to explain it.